90 related articles for article (PubMed ID: 37228617)
1. Differences in the phenotypes and transcriptomic signatures of chimeric antigen receptor T lymphocytes manufactured
Niu A; Zou J; Hu X; Zhang Z; Su L; Wang J; Lu X; Zhang W; Chen W; Zhang X
Front Immunol; 2023; 14():1068625. PubMed ID: 37228617
[TBL] [Abstract][Full Text] [Related]
2. Development of a microfluidic cell transfection device into gene-edited CAR T cell manufacturing workflow.
Yu T; Jhita N; Shankles P; Fedanov A; Kramer N; Raikar SS; Sulchek T
Lab Chip; 2023 Nov; 23(22):4804-4820. PubMed ID: 37830228
[TBL] [Abstract][Full Text] [Related]
3. [Effect of signal peptide optimized by site-directed mutagenesis on the function of chimeric antigen receptor T cells].
Liu Y; Li F; Dai H; Zhou R; Wang M; Gan S; Xu Y
Sheng Wu Gong Cheng Xue Bao; 2024 Feb; 40(2):573-584. PubMed ID: 38369842
[TBL] [Abstract][Full Text] [Related]
4. Transposon-Based Manufacturing of Human CAR-T Cells.
Tennant M; O'Neil R
Methods Mol Biol; 2024; 2748():187-199. PubMed ID: 38070116
[TBL] [Abstract][Full Text] [Related]
5. [Construction and identification of a stable CT26 cell line expressing CD19-FLUC-GFP].
Guo Y; Duan H; Cheng Y; Yang B; Hu H; Liu B; Wang Y
Sheng Wu Gong Cheng Xue Bao; 2024 Feb; 40(2):458-472. PubMed ID: 38369833
[TBL] [Abstract][Full Text] [Related]
6. Manufacturing NKG2D CAR-T cells with piggyBac transposon vectors and K562 artificial antigen-presenting cells.
Tay JCK; Wang J; Du Z; Ng YY; Li Z; Ren Y; Zhang C; Zhu J; Xu XH; Wang S
Mol Ther Methods Clin Dev; 2021 Jun; 21():107-120. PubMed ID: 33816644
[TBL] [Abstract][Full Text] [Related]
7. Revealing the impact of CD70 expression on the manufacture and functions of CAR-70 T-cells based on single-cell transcriptomics.
Cheng J; Zhao Y; Hu H; Tang L; Zeng Y; Deng X; Ding S; Guo AY; Li Q; Zhu X
Cancer Immunol Immunother; 2023 Oct; 72(10):3163-3174. PubMed ID: 37382633
[TBL] [Abstract][Full Text] [Related]
8. Engineering Efficient CAR-T Cells via Electroactive Nanoinjection.
Shokouhi AR; Chen Y; Yoh HZ; Brenker J; Alan T; Murayama T; Suu K; Morikawa Y; Voelcker NH; Elnathan R
Adv Mater; 2023 Nov; 35(44):e2304122. PubMed ID: 37434421
[TBL] [Abstract][Full Text] [Related]
9. CD8
Lee SY; Lee DH; Sun W; Cervantes-Contreras F; Basom RS; Wu F; Liu S; Rai R; Mirzaei HR; O'Steen S; Green DJ; Shadman M; Till BG
J Immunother Cancer; 2023 Nov; 11(11):. PubMed ID: 38251688
[TBL] [Abstract][Full Text] [Related]
10. Promoter choice: Who should drive the CAR in T cells?
Rad S M AH; Poudel A; Tan GMY; McLellan AD
PLoS One; 2020; 15(7):e0232915. PubMed ID: 32706785
[TBL] [Abstract][Full Text] [Related]
11. Single-cell transcriptome analysis of CAR T-cell products reveals subpopulations, stimulation, and exhaustion signatures.
Wang X; Peticone C; Kotsopoulou E; Göttgens B; Calero-Nieto FJ
Oncoimmunology; 2021 Jan; 10(1):1866287. PubMed ID: 33489472
[TBL] [Abstract][Full Text] [Related]
12. Ligand-based, piggyBac-engineered CAR-T cells targeting EGFR are safe and effective against non-small cell lung cancers.
Chinsuwan T; Hirabayashi K; Mishima S; Hasegawa A; Tanaka M; Mochizuki H; Shimoi A; Murakami T; Yagyu S; Shimizu K; Nakazawa Y
Mol Ther Oncolytics; 2023 Dec; 31():100728. PubMed ID: 37822488
[TBL] [Abstract][Full Text] [Related]
13. Automating CAR-T Transfection with Micro and Nano-Technologies.
Hu T; Kumar AR; Luo Y; Tay A
Small Methods; 2023 Dec; ():e2301300. PubMed ID: 38054597
[TBL] [Abstract][Full Text] [Related]
14. Lipid nanoparticles outperform electroporation in mRNA-based CAR T cell engineering.
Kitte R; Rabel M; Geczy R; Park S; Fricke S; Koehl U; Tretbar US
Mol Ther Methods Clin Dev; 2023 Dec; 31():101139. PubMed ID: 38027056
[TBL] [Abstract][Full Text] [Related]
15. An efficient low cost method for gene transfer to T lymphocytes.
Chicaybam L; Sodre AL; Curzio BA; Bonamino MH
PLoS One; 2013; 8(3):e60298. PubMed ID: 23555950
[TBL] [Abstract][Full Text] [Related]
16. B-cell-directed CAR-T cell therapy activates CD8+ cytotoxic CARneg bystander T-cells in non-human primates and patients.
Kaminski J; Fleming RA; Alvarez-Calderon F; Winschel MB; McGuckin C; Ho EE; Eng F; Rui X; Keskula P; Cagnin L; Charles J; Zavistaski JM; Margossian SP; Kapadia M; Rottman JB; Lane J; Baumeister SHC; Tkachev V; Shalek A; Kean LS; Gerdemann U
Blood; 2024 Apr; ():. PubMed ID: 38558106
[TBL] [Abstract][Full Text] [Related]
17. Mechanical Stimulation after Centrifuge-Free Nano-Electroporative Transfection Is Efficient and Maintains Long-Term T Cell Functionalities.
Tay A; Melosh N
Small; 2021 Sep; 17(38):e2103198. PubMed ID: 34396686
[TBL] [Abstract][Full Text] [Related]
18. Separation of Activated T Cells Using Multidimensional Double Spiral (MDDS) Inertial Microfluidics for High-Efficiency CAR T Cell Manufacturing.
Jeon H; Perez CR; Kyung T; Birnbaum ME; Han J
Anal Chem; 2024 Jun; ():. PubMed ID: 38889002
[TBL] [Abstract][Full Text] [Related]
19. Signatures of dysfunctional CAR T cells.
Maus MV
Blood; 2023 Jun; 141(26):3127-3129. PubMed ID: 37383003
[No Abstract] [Full Text] [Related]
20. IRF4 downregulation improves sensitivity and endurance of CAR T cell functional capacities.
Harrer DC; Bezler V; Hartley J; Herr W; Abken H
Front Immunol; 2023; 14():1185618. PubMed ID: 37287982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
